跳至主要内容
临床试验/NCT00003420
NCT00003420已完成不适用

A Study of CT Scan Frequency in Patients With Stage I Testicular Teratoma

Medical Research Council1 个研究点 分布在 1 个国家目标入组 900 人开始时间: 1997年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
900
试验地点
1

研究概览

简要总结

RATIONALE: Imaging procedures such as CT scans help the doctor in detecting cancer or the recurrence of cancer. Increasing the number of times a CT scan is given may improve the ability to detect stage I testicular cancer.

PURPOSE: Randomized clinical trial to determine if there is a different result from two different schedules of CT scans in treating patients with stage I testicular cancer after undergoing orchiectomy.

详细描述

OBJECTIVES:

  • Determine whether there is a difference between two schedules of CT scan surveillance in respect to stage of disease at relapse, survival, the investigation determining relapse, and incidence of second malignancies in patients with stage I testicular teratoma after orchidectomy.

OUTLINE: This is a randomized, multicenter study. Patients are stratified by center and presence of vascular invasion.

After orchidectomy, patients are randomized into two schedules (arms I and II) of CT scan follow up.

  • Arm I: Patients repeat chest and abdominal CT scans no later than 3 months after orchidectomy and again at 12 months to confirm that the patient is clear of disease.
  • Arm II: Patients repeat chest and abdominal CT scans at 3, 6, 9, 12, and 24 months after orchidectomy.

研究设计

研究类型
Interventional
分配方式
Randomized
主要目的
Diagnostic

入排标准

性别
Male
接受健康志愿者
否

入选标准

  • •DISEASE CHARACTERISTICS:
  • •Histologically confirmed nonseminomatous germ cell tumor of the testis Stage I disease:
  • •No evidence of metastatic disease on clinical examination
  • •Normal chest x-ray
  • •Normal chest and abdominal CT scan
  • •Normal serum tumor marker (AFP, HCG) after orchidectomy
  • •High risk patients should be considered for ongoing studies of adjuvant chemotherapy after orchidectomy, but those choosing not to take this option may enter this study
  • •Orchidectomy no greater than 8 weeks prior to randomization into this study
  • •PATIENT CHARACTERISTICS:
  • •Not specified
  • •Performance status:
  • •Not specified
  • •Life expectancy:
  • •Not specified
  • •Hematopoietic:
  • •Not specified
  • •Not specified
  • •Not specified
  • •No other concurrent or prior malignancy except successfully treated nonmelanomatous skin cancer
  • •PRIOR CONCURRENT THERAPY:
  • •Biologic therapy:
  • •Not specified
  • •Chemotherapy:
  • •Not specified
  • •Endocrine therapy:
  • •Not specified
  • •Radiotherapy:
  • •Not specified
  • •See Disease Characteristics

排除标准

  • 未提供

研究者

申办方类型
Other Gov

研究点 (1)

Loading locations...

相似试验